Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zentalis Pharmaceuticals
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
- Other Names / Subsidiaries
- Zeno Pharma, LLC
- Zeno Pharmaceuticals, Inc.
- Zentera Therapeutics